5 completed, 1 active not recruiting, 1 terminated, 1 unknown. 8 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 5, Active not recruiting 1, Terminated 1, Unknown 1 |
| Phase 1 | 4 | Completed 3, Unknown 1 |
Follow chiauranib: new trials by email Literature Review of chiauranib trials Research Report on chiauranib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma Chiauranib, Albumin-paclitaxel Injection, Gemcitabine Injection - Pancreatic Ductal Adenocarcinoma | Phase 2 | Active not recruiting | Chipscreen Biosciences, Ltd. | 42 | 2024-08-13 | 2026-10-23 |
| Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. Chiauranib - Small Cell Lung Cancer, Advanced Solid Malignant Tumor | Phase 1 / Phase 2 | Unknown | Chipscreen Biosciences, Ltd. | 36 | 2022-08-26 | 2024-07-16 |
| Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS) Chiauranib - Soft Tissue Sarcoma | Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 40 | 2022-08-25 | 2025-04-03 |
| A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC Chiauranib, capecitabine - Triple-negative Breast Cancer | Phase 2 | Terminated | Chipscreen Biosciences, Ltd. | 9 | 2021-11-05 | 2025-03-24 |
| Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma Chiauranib, Chidamide - Non-hodgkin's Lymphoma | Phase 1 / Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 9 | 2019-07-11 | 2022-03-09 |
| Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer chiauranib, etoposide, paclitaxel - Ovarian Cancer | Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 47 | 2019-07-01 | 2021-03-19 |
| Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma Chiauranib - Hepatocellular Carcinoma | Phase 1 / Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 27 | 2018-04-28 | 2021-06-18 |
| Phase Ib Study of Chiauranib in Patients With Ovarian Cancer Chiauranib - Ovarian Cancer | Phase 1 / Phase 2 | Completed | Chipscreen Biosciences, Ltd. | 25 | 2017-12-15 | 2020-01-18 |
Ovarian Neoplasms (2) · Recurrence (2) · Carcinoma, Hepatocellular (1) · Lymphoma, Non-Hodgkin (1) · Sarcoma (1) · Small Cell Lung Carcinoma (1) · Triple Negative Breast Neoplasms (1)
Chipscreen Biosciences, Ltd. (8)
China (7) · United States (1)
Cabilia Pichardo, MD (1) · Xianjun Yu (1) · Xiaohua Wu (1) · Xing Zhang, MD (1)